Monopoly Rights for Essential Dorzolamide Drops

High Profit Margins from Stable Chronic Glaucoma Segment

Dorshell Edge: Trusted CAI for IOP Reductionn

Secure Exclusive Territory in Ophthalmic Chronic Care

Low Investment, Full Technical Marketing Support
Start Your High-Value Glaucoma Business Today

Home/Products /dorzolamide-hydrochloride-ip-2-w-v-benzalkonium-chloride-eye-drop

Dorshell Eye Drops

Composition : Dorzolamide (2% w/v) Eye Drop

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Dorshell Eye Drop (Dorzolamide 2% w/v) is a high-profit chronic care product built for our PCD Pharma Franchise partners.

This eye drop is a powerful Carbonic Anhydrase Inhibitor (CAI) widely used by ophthalmologists, either alone or in combination, to effectively reduce Intraocular Pressure (IOP) in patients with glaucoma or ocular hypertension. Since glaucoma requires lifelong treatment, this product guarantees stable, long-term prescription refills.

Why Dorshell is Your Key to Profit:

  1. Stable, Long-Term Demand: As a cornerstone drug for chronic glaucoma management, Dorzolamide ensures consistent, recurring revenue based on chronic patient needs, providing financial stability.

  2. Excellent Specialty Margin: Positioned in the high-value ophthalmic segment, this product commands superior pricing and secures some of the highest profit margins within specialty eye care.

  3. Doctor Loyalty: The established efficacy of Dorzolamide ensures its position as a primary choice for specialists, building strong, reliable prescription loyalty.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics. Partner with us for full marketing support and reliable supply to convert this high-value product into guaranteed business growth.

Contact us today to capture this high-margin chronic care segment!

Read More

About the Product

Dorshell Eye Drop (Dorzolamide 2% w/v) is a high-profit chronic care product built for our PCD Pharma Franchise partners.

This eye drop is a powerful Carbonic Anhydrase Inhibitor (CAI) widely used by ophthalmologists, either alone or in combination, to effectively reduce Intraocular Pressure (IOP) in patients with glaucoma or ocular hypertension. Since glaucoma requires lifelong treatment, this product guarantees stable, long-term prescription refills.

Why Dorshell is Your Key to Profit:

  1. Stable, Long-Term Demand: As a cornerstone drug for chronic glaucoma management, Dorzolamide ensures consistent, recurring revenue based on chronic patient needs, providing financial stability.

  2. Excellent Specialty Margin: Positioned in the high-value ophthalmic segment, this product commands superior pricing and secures some of the highest profit margins within specialty eye care.

  3. Doctor Loyalty: The established efficacy of Dorzolamide ensures its position as a primary choice for specialists, building strong, reliable prescription loyalty.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics. Partner with us for full marketing support and reliable supply to convert this high-value product into guaranteed business growth.

Contact us today to capture this high-margin chronic care segment!

The eye drop is generally well-tolerated. Mild side effects may include temporary stinging, burning, or slight redness upon application. Rarely, allergic reactions such as itching, swelling, or increased irritation may occur. Discontinue use and consult a healthcare professional if severe reactions develop.

Lubicom Ultra Eye Drop is indicated for relief from dry eyes, irritation, and oxidative stress-related ocular discomfort. It helps in lubricating the eyes, protecting against free radical damage, and improving overall eye health. It may also support visual clarity and reduce age-related oxidative changes in the eyes.

Use Lubicom Ultra Eye Drop exactly as directed. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. This product is for ocular use only and should not be swallowed.

Store Lubicom Ultra Eye Drop in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children. Discard any unused solution after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation